Rapport Therapeutics, Inc. Common Stock (RAPP) — Financial Flexibility Index
Rapport Therapeutics, Inc. Common Stock (RAPP) has a Financial Flexibility Index of -1.51x as of June 2026. Free cash flow of $-54.35 Million (operating CF $-54.52 Million minus capex $164.00K) represents -2% of total liabilities ($36.06 Million). Check tangible equity quality of Rapport Therapeutics, Inc. Common Stock to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Rapport Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Rapport Therapeutics, Inc. Common Stock across 4 annual periods. For the full cash flow conversion analysis, see RAPP cash flow conversion.
Annual Financial Flexibility Index for Rapport Therapeutics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for Rapport Therapeutics, Inc. Common Stock. Explore RAPP debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.13x | $-86.86 Million | $-87.47 Million | $27.78 Million | ▲ +52.4% |
| 2024 | -6.57x | $-62.42 Million | $-64.83 Million | $9.51 Million | ▼ -4554.3% |
| 2023 | -0.14x | $-25.55 Million | $-27.18 Million | $181.06 Million | ▲ +42.3% |
| 2022 | -0.24x | $-2.96 Million | $-3.24 Million | $12.10 Million | — |